naproxen has been researched along with 11-dehydro-2,3-dinor-thromboxane b2 in 1 studies
Studies (naproxen) | Trials (naproxen) | Recent Studies (post-2010) (naproxen) | Studies (11-dehydro-2,3-dinor-thromboxane b2) | Trials (11-dehydro-2,3-dinor-thromboxane b2) | Recent Studies (post-2010) (11-dehydro-2,3-dinor-thromboxane b2) |
---|---|---|---|---|---|
4,551 | 1,057 | 1,429 | 5 | 1 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anzellotti, P; Capone, ML; Di Francesco, L; Di Gregorio, P; Merciaro, G; Patrignani, P; Sciulli, MG; Tacconelli, S | 1 |
1 trial(s) available for naproxen and 11-dehydro-2,3-dinor-thromboxane b2
Article | Year |
---|---|
Human pharmacology of naproxen sodium.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Arachidonic Acid; Aspirin; Blood Platelets; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Epoprostenol; Humans; Lipopolysaccharides; Monocytes; Naproxen; Platelet Aggregation; Thromboxane B2 | 2007 |